Collaboration for Outcomes Using Social Media in Oncology (COSMO)

Providence, RI US
September 18, 2024 to September 19, 2024

The Collaboration for Outcomes Using Social Media in Oncology (COSMO) has organized the second Conference on Social Media in Oncology

Register Today To Secure Your Spot - Limited seating is available!

Patients are increasingly turning to the internet and social media for health information. It can be difficult to find reliable health information online, especially in the age of online misinformation. Healthcare professionals are essential in fighting cancer misinformation online.

2024 COSMO Conference Highlights 
  • Using Social Media to Support Diversity, Equity, and Inclusion in Oncology
  • Using Social Media for Research 
  • Creating Meaningful Engagement with Advocates, Physicians, and Reputable Sources of Information 
  • Exploring the Role of the Digital Opinion Leader 
  • Industry Relations, Partnership, and Transparency 
  • Physicians, Patient Advocates, Platform Providers, Health Information Providers 

The availability of information online and through social media has changed how patients engage with each other and their medical teams. According to Rutten and colleagues, nearly 70% report that their initial health of medical information source is the internet1. For people diagnosed with and living beyond cancer, the proportion using the internet as a source of information ranges from 60 to 80%2. Indeed, in oncology, the “rapid diffusion and adoption of social media have created a new frontier in cancer communication”.

While patient access to online cancer-specific information has skyrocketed, judgment over what is reliable and what is not continues to be a significant issue. In this area of uncertainty, trust in health care professionals remains stable, with 94% of Americans trusting clinicians compared with 64% who trust what is found on the Internet. These data suggest that clinicians remain not only relevant but important sources of interpretation for health information, including what is found online, especially with mounting concerns over health misinformation online
 
Online health information can potentially improve health outcomes, shared decision-making, choice, quality of life, adherence and reduce suffering and health care costs. Yet, patients struggle with discerning what information is accurate, trustworthy, and reliable. As Grimes pointed out in a 2022 commentary, while cancer misinformation (e.g., false promises and claims not backed by data) is not a phenomenon borne out of social media, the rapidity and reach afforded through social media is. The reasons for this are varied but include that likelihood of accepting misinformation may be rooted in inherent distrust of conventional medicine, the ever-evolving understanding of cancer biology and the emergence of new therapies, and the sheer ubiquity of cancer misinformation, often coupled with anecdotes to support them. These data highlight the ongoing threat that misinformation places on people interested in, diagnosed with, and living after cancer face when utilizing the internet, including social media.
 
COSMO has worked to provide a roadmap on how best to engage the individual physician and b) the professional community. Our overarching mission has been to encourage stronger and more diverse social media participation for oncology professionals, to define the metrics of engagement in a way that demonstrates value to all stakeholders (including those impacted by cancer and the public at large), and to provide a venue for ongoing social media research in oncology.

Target Audience

The target audience for the COSMO meeting encompasses a diverse and multidisciplinary group dedicated to advancing oncology care through social media engagement. This includes oncology physicians, who bring clinical expertise; trainees, who represent the future of oncology; and advanced practice providers & nurses, who play a crucial role in patient care. Patient advocates are essential for their insights into patient needs and experiences, while healthcare communication experts can offer strategies to effectively disseminate accurate information. Finally, industry partners contribute by fostering innovation and supporting research initiatives. Together, these stakeholders aim to enhance oncology communication, combat misinformation, and improve patient outcomes through collaborative efforts.

Learning Objectives

  • Identify opportunities and challenges to engagement by different social media platforms as it relates to professional development, bidirectional communication, and sharing of research
  • Better understand the research areas under investigation within oncology as it relates to social media
  • Distinguish between digital opinion leaders from key opinion leaders or from medical influencers and to better identify how DOLs can collaborate on social media on issues related to and about oncology

 

     

     

    Additional Information

    AttachmentSize
    PDF icon COSMO 2024 flyer.pdf195.79 KB
    PDF icon COSMO.BROCHURE2024.2.pdf534.22 KB
    Course summary
    Available credit: 
    • 8.25 AMA PRA Category 1 Credit™
      The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    • 8.25 Attendance
      Participants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.
    Course opens: 
    07/01/2024
    Course expires: 
    12/02/2024
    Event starts: 
    09/18/2024 - 7:00am EDT
    Event ends: 
    09/19/2024 - 4:30pm EDT
    Cost:
    $75.00
    Add to calendar: 

    COSMO 2024 AGENDA

    Wednesday 9/18/2024 

     
    4:00 - 4:05 pm     Welcome
                                         Conference Co-Chairs: Eleonora Teplinsky, MD and Martina Murphy, MD 
     

    4:10 - 4:30             Using Social Media to Support Diversity, Equity & Inclusion (DEI) in Oncology
                                         Narjust Florez, MD, FASCO

     

    4:30 - 5:30            Breakout Sessions

                                     A | Medical Communication (Education, Peer to Peer Engagement, Preferred Social Media Platforms)
                                           Moderator: Martina Murphy, MD 
     
                                     B | Community Building & Stakeholder Engagement 
                                           Moderator: Roberta Lombardi
     

    5:35 - 6:00             Group Discussion
                                         Co-Chairs: Eleonora Teplinsky, MD and Martina Murphy, MD

     

    6:00 - 7:00             Welcome Reception

     

    Thursday 9/19/2024

     

    7:00 - 8:00 am        Breakfast and Registration

     
    8:00 - 8:15               Welcome and Introductory Remarks
                                       Conference Co-Chairs: Eleonora Teplinsky, MD and Martina Murphy, MD
     

                                      General Session 1: “Building an Oncology Community Through Social Media”

     
    8:15 - 9:00               Roundtable One | Engaging with Patient Communities on Social Media & Reaching a Broader Audience  
                                      Moderator: Amy Comander, MD  
                                      Panelists: Darcy Burbage, DNP, RN, AOCN, CBCN | Anne Marie Mercurio | Krishna Soujanya Gunturu, MD
     
    9:05 - 9:25              COSMO and Community       
                                      Don Dizon, MD, FACP, FASCO
     
    9:30 - 10:25          Roundtable Two | Social Media as a Venue for Networking and Professional Support in Oncology - How I Find My Tribe on Social Media 
                                       Moderator: Krishna Soujanya Gunturu, MD
                                       Panelists: Maryam Lustberg, MD, MPH | Maura (Molly) Barry, MD | Emily Drake, BScH, MA 
     

    10:25 - 10:50           BREAK  

     
                                       General Session 2 | Social Media Clinical Research 
                                       This session will focus on NIH and other supported research in social media and oncology. 
                                       Moderator: Wen-Ying Sylvia Chou, PhD, MPH 
     
    10:55 - 11:20           Women in Medicine 
                                      Shikha Jain, MD, FACP
     
    11:25 - 11:50            Cancer Misinformation On Social Media And Its Correction
                                      Stacy Loeb, MD, MSc, PhD (hon)
     
    11:55 - 12:40           Roundtable Three | Funding Social Media-Based Research: Tips and Challenges
                                      Moderator: Wen-Ying Sylvia Chou, PhD, MPH
                                      Panelists: Jeremy Warner, MD, MS, FAMIA, FASCO | Stacy Loeb, MD, MSc, PhD | Shikha Jain, MD FACP
     

    12:40 - 1:30 pm    LUNCH 

                                      General Session 3 | Objectives and Goals for the Individual's Professional Use of Social Media
                                        in Oncology: The (r)evolution of the Digital Opinion Leader 
                                      This session will focus on participants’ social media goals, including how to get more involved in
                                      social media-based research in oncology  and how to grow on social media, including a talk on
                                      digital opinion social media can serve the individual leaders. The goal is to highlight how social
                                      media can serve the individual The goal is to highlight how so
                                      (whether through advocacy, networking, building a private practice.


    1:30 - 2:00             KEYNOTE | Cancer and Covid-19 Consortium (CCC19)- Collaborative research in oncology
                                        Jeremy L. Warner, MD, MS, FAMIA, FASCO 

     
    2:05 - 2:50             Roundtable Four | Bidirectionality of Social Media: Efforts and Outcomes
                                    Moderator: Don S. Dizon, MD, FACP, FASCO
                                    Panelists: Steve Alperin | Nagla Abdel Karim, MD | Jonathan Sommers, BA, BCPA | Stacey Tinianov, MPH
     

    2:50 - 3:00             BREAK 

     

    3:00 - 3:20             The Digital Opinion Leader & Ethics of Engagement: Disclosure, Partnerships, and Authenticity
                                         Eleonora Teplinsky, MD

     

    3:25 - 4:10              Roundtable Five | The Digital Opinion Leader: Defining It and Collaborating Challenges
                                      Moderator: Martina Murphy, MD
                                      Panelists: Stephanie Graff, MD |     Nafeez Zawahir, MD | Julie Carmen, PharmD, BCPS

     

    4:15 - 4:30              Conference Summary & Wrap Up

    Providence Marriot Downtown
    1 Orms Street
    Providence, RI 02904
    United States

    A block of rooms has been reserved for COSMO 2024 attendees. 

    Special Group Rate: $189 USD per night plus applicable taxes

    Reserve your room now at:  Book your group rate for Brown Cosmo Meeting

    Last Day to Book: Sunday, September 1, 2024

    Conference Chairs

    Martina Murphy, MD
    Associate Professor, Department of Medicine
    Vice Chief for Faculty Development, Division of Hematology/Oncology
    Senior Associate Dean for Graduate Medical Education
    University of Florida
    Gainesville, FL
     
    Eleonora Teplinsky, MD
    Clinical Assistant Professor, Department of Medicine
    Icahn School of Medicine of Mount Sinai 
    Head of Breast and Gynecologic Medical Oncology, Valley Health System 
    New York, NY
     

    Guest Speakers and Panelists

     
    Steve Alperin
    CEO of SurvivorNet
    New York, NY
     
    Maura (Molly) Barry, MD
    Associate Professor of Medicine
    Division of Hematology/Oncology
    Larner College of Medicine
    University of Vermont Medical Center
    Burlington, VT
     
    Darcy Burbage, DNP, RN, AOCN, CBCN
    Consulting Associate
    Duke University School of Nursing
    Oncology Clinical Nurse Specialist
    Durham, NC
     
    Julie Carmen, PharmD, BCPS
    Associate Director, Digital Insights-Solid Tumor Oncology
    Johnson & Johnson
    Oncology Medical Affairs, Medical Excellence
    Pittsburg, PA 
     
    Wen-Ying Sylvia Chou, PhD, MPH 
    Program Director
    National Cancer Institute
    Washington, DC
     
    Amy Comander, MD, DipABLM
    Medical Director, Massachusetts General Cancer Center-Waltham
    Director, Breast Oncology Program
    Massachusetts General Hospital Cancer Center-Waltham and Newton-Wellesley Hospital
    Boston, MA
     
    Don S Dizon, MD, FACP, FASCO
    Professor of Medicine and Professor of Surgery
    Warren Alpert Medical School of Brown University
    Associate Director, Community Outreach and Engagement
    Legorreta Cancer Center at Brown
    Director, Pelvic Malignancies Program, Brown University Health
    Director, Medical Oncology, Rhode Island Hospital
    Providence, RI
     
    Emily Drake, BScH, MA
    PhD in Health Candidate, School of Nursing
    Dalhousie University
    Halifax, NS, Canada
     
    Narjust Florez, MD, FASCO
    Assistant Professor of Medicine, Harvard Medical School
    Associate Director, The Cancer Care Equity Program
    Dana-Farber Cancer Institute
    Boston, MA
     
    Stephanie L. Graff, MD, FACP, FASCO
    Associate Professor of Medicine, Brown University
    Director of Breast Oncology, Brown University Health
    Providence, RI 
     
    Krishna Soujanya Gunturu, MD    
    Associate Chief, Clinical Trials and Correlative Science Research
    Hartford Cancer Institute
    Site Director, Hematology and Medical Oncology 
    The Hospital of Central Connecticut
    Hartford, CT  
     
    Shikha Jain, MD, FACP
    Assistant Professor of Medicine 
    Director of Communication Strategies in Medicine
    University of Illinois College of Medicine 
    Associate Director of Oncology Communication & Digital Innovation
    University of Illinois Cancer Center
    Chicago, IL
     
    Nagla Abdel Karim, MD, PhD
    Professor of Medicine
    University of Virginia 
    Director of Phase I Program 
    Inova Schar Cancer Institute  
    Washington, DC
     
    Stacy Loeb, MD, MSc, PhD (hon)
    Professor of Urology and Population Health
    New York University Langone Health and Manhattan VA
    New York, NY
     
    Roberta Lombardi 
    Founder and President
    Infinite Strength
     
    Maryam Lustberg, MD, MPH
    Associate Professor of Internal Medicine
    Director, Center for Breast Cancer
    Chief, Breast Medical Oncology
    New Haven, CT
     
    Anne Marie Mercurio
    Co-Chair of the Patient Advocate Committee at SWOG Cancer Research Network (NCI NCTIN)
    Ponte Vedra Beach, FL
     
    Jonathan Sommers, BA, BCPA
    Board-certified Patient Advocate
    Denver, CO 
     
    Stacey Tinianov, MPH, BCPA
    Santa Cruz, CA 
     
    Jeremy L. Warner, MD, MS, FAMIA, FASCO
    Professor of Medicine and Biostatistics
    Brown University
    Lifespan Cancer Institute
    Providence, RI
     
    Nafeez Zawahir, MD
    Chief Medical Officer
    Razorfish Health
    New York, NY
     
    Planning Committee

    • Eleonora Teplinsky, MD

    • Martina Murphy, MD

    • Don S Dizon, MD, FACP, FASCO

    • Maria Sullivan, Director, Office of Continuing Medical Education, Brown University, Providence, RI 

    • Michelle King, CME Coordinator, Office of Continuing Medical Education, Brown University, Providence, RI 

    • Deborah Augustus, Vice President, Educational Strategy, Integrity CE, LLC, Orlando, FL

     
     

    The Warren Alpert Medical School of Brown University is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Warren Alpert Medical School of Brown University and the Collaboration for Outcomes using Social Media in Oncology. The Warren Alpert Medical School of Brown University  is accredited by the ACCME to provide continuing medical education for physicians.

    Physicians: The Warren Alpert Medical School of Brown University designates this live activity for a maximum of 8.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Other Healthcare Providers: Participants will receive a Certificate of Attendance stating this program is designated for 8.25 hours AMA PRA Category 1 CreditsTM. Many other disciplines accept AMA PRA Category 1 CreditsTM towards re-licensure or re-certification. Check with your state licensing board to verify.

    Available Credit

    • 8.25 AMA PRA Category 1 Credit™
      The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    • 8.25 Attendance
      Participants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.

    Healio is the Official Media Partner of COSMO 2024

    FUNDING for COSMO 2024 provided by: 

    • American Cancer Society 
    • ImmunoGen
    • Paxman Scalp Cooling
    • SurvivorNet
    • Warren Alpert Medical School Division of Hematology/Oncology, Department of Medicine 
    • Legorreta Cancer Center at Brown University 
    • Center for Clinical Cancer Informatics and Data Science, Brown University Health Cancer Center 

     

    Price

    Cost:
    $75.00
    Please login or register to take this course.

    Registration includes up to 8.25 hours of CME credits, Welcome Reception on 9/18, and breakfast & lunch on 9/19, Parking.

    Pre-registration is required | To register, you must first log in or create an account by clicking "My Account" underneath the Brown Medical School logo.

    REGISTRATION FEES:

     

    Early Bird Rate Available through 8/25/24

    Rate Change as of 8/26/24

    Health Care Professionals

     

    $75

    $150

    Industry

     

     $399

     $599

    Health Professions Trainees 

     

    		      $25      $25

    Patient & Patient Advocate

     

    $25

    $25

    Government Employees

     

    $25

    $25

    Accommodations
    Please email the Brown CME Office at CME@Brown.edu at least four weeks before the conference to request reasonable accommodations. 

    Cancellation Policy
    Cancellations/substitutions must be made in writing to the Brown CME Office at least three weeks before the conference, no later than August 27, 2024. A $50.00 administrative fee will be charged for all refunds (no refunds for “no shows”). There will be no additional charge for substitutions. This conference is subject to change or cancellation

    For More Information, Contact Brown Continuing Medical Education
    Ph: 401-863-5254 | E: CME@Brown.edu | Website: www.cme.med.brown.edu